US20150208959A1 - Lancet analyte sensors and methods of manufacturing - Google Patents
Lancet analyte sensors and methods of manufacturing Download PDFInfo
- Publication number
- US20150208959A1 US20150208959A1 US14/681,684 US201514681684A US2015208959A1 US 20150208959 A1 US20150208959 A1 US 20150208959A1 US 201514681684 A US201514681684 A US 201514681684A US 2015208959 A1 US2015208959 A1 US 2015208959A1
- Authority
- US
- United States
- Prior art keywords
- analyte
- sensor
- cavity
- sensor body
- core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
- A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150213—Venting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150274—Manufacture or production processes or steps for blood sampling devices
- A61B5/150282—Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
- A61B5/150396—Specific tip design, e.g. for improved penetration characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
- A61B5/150427—Specific tip design, e.g. for improved penetration characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
- A61B5/150511—Details of construction of shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150977—Arrays of piercing elements for simultaneous piercing
- A61B5/150984—Microneedles or microblades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15105—Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
- A61B5/15119—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising shape memory alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
- A61B5/15123—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising magnets or solenoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/685—Microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
- A61B2562/125—Manufacturing methods specially adapted for producing sensors for in-vivo measurements characterised by the manufacture of electrodes
Definitions
- the present invention relates to electrochemical analyte sensors that may be used to detect an analyte concentration level in a bio-fluid sample taken from a patient.
- an electrochemical analyte sensor may be employed for the monitoring of a patient's blood glucose level as part of diabetes treatment and care.
- An electrochemical analyte sensor may be employed discretely (‘discrete monitoring’), for instance, by detecting an analyte concentration level in a single sample of blood or other interstitial fluid obtained from the patient by a lancet (e.g., by a pin-prick or needle).
- the analyte sensor may be employed continuously (‘continuous monitoring’), by implanting a sensor in the patient for a duration of time. In discrete monitoring, there may be a separation between the sample collection process and the measurement of the analyte concentration level.
- the sample may then be transferred to a medium (e.g., a test strip or a detector) for measurement of the sample's analyte concentration level.
- a medium e.g., a test strip or a detector
- analyte sensor adapted for bio-fluid analyte monitoring that is minimally invasive during sample collection, and yet consistently and readily provides for accurate analyte concentration level measurements from the obtained bio-fluid sample.
- the present invention provides an analyte sensor, including a sensor body comprised of a semiconductor material; an active region coupled to the sensor body; and a lancet formed on an end of the analyte sensor.
- the present invention provides an analyte sensor for detecting an analyte concentration level in a bio-fluid sample, including a core comprised of a conductive material; a cladding comprised of a semiconductor material surrounding the core; a cavity formed proximate to the core, and an active region provided within the cavity.
- the present invention provides an analyte sensor for detecting an analyte concentration level in a bio-fluid sample, including a fiber comprised of a semiconductor material; an active region in contact with the fiber, and a lancet formed on the analyte sensor.
- the present invention provides a testing apparatus, including an analyte sensor having a sensor body comprised of a semiconductor material; an active region coupled to the sensor body; and a lancet formed on an end of the analyte sensor.
- the present invention provides a method of manufacturing an analyte sensor, including providing a fiber comprised of a semiconductor material; forming a cavity proximate to the fiber, forming an active region in the cavity, and forming lancet on the analyte sensor.
- FIG. 1A is a cross-sectional view of an exemplary embodiment of an analyte sensor provided according to the present invention.
- FIG. 1B is a perspective view of the analyte sensor according to the exemplary embodiment shown in FIG. 1A .
- FIG. 2 is a cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 3 is a partial cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 4 is a cross-sectional view of another exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 5 is a cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 6 is a cross-sectional view of an additional exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 7A is a cross-sectional view of an additional exemplary embodiment of an analyte sensor according to the present invention.
- FIG. 7B is a frontal view of the exemplary embodiment of the analyte sensor of FIG. 7A .
- FIGS. 8 and 9 are cross-sectional views of additional exemplary embodiments of analyte sensors according to the present invention.
- FIG. 10 is a frontal view of an apparatus including an array of analyte sensors according to the present invention.
- FIG. 11 is a flowchart illustrating a method of manufacturing lancet analyte sensors according to the present invention.
- a lancet analyte sensor that integrates the functions of a lancet and an analyte sensor into a single device. In this manner, the processes of sample collection and analyte detection may be performed without the need to transfer the sample to a transfer medium, such as an analyte sensor strip or an external detection or testing device.
- An exemplary lancet analyte sensor may include a sensor body comprised of a semiconductor material.
- the sensor body in some embodiments may include a core including a conductive material and a cladding.
- the conductive core of the analyte sensor may comprise carbon (e.g., graphite) and the semiconductor cladding may comprise silicon carbide.
- a lancet may be formed on the analyte sensor.
- Lancet is defined herein as a sharpened area or point that is provided on an end of the lancet analyte sensor.
- a cladding of the conductor may be cleaved at an angle at one end to provide a lancet for insertion.
- the lancet may be a separate member and may be otherwise coupled to the sensor body, such as to the cladding for example.
- the analyte sensor may include a cavity located proximate to the sensor body (e.g., proximate the core) for accepting the bio-fluid sample.
- the term “cavity” as defined herein is a hollow, indented, or concave area having walls adapted to contain and confine the bio-fluid sample.
- the cavity may be at least partially surrounded by the cladding whereby the walls of the cavity are formed by the cladding material (e.g., by an inner surface of the cladding).
- the cavity is at least partially formed by walls of a lancet member connected to the sensor body.
- the cavity may be formed in a peripheral side wall of the sensor body.
- the cavity may be provided with an active region which may be coupled to the core and/or cladding and may be adapted to generate an electrical current which may be proportional to an analyte concentration level.
- the diameter of the lancet analyte sensor may be smaller than conventional lancets, such that the lancet analyte sensor may be inserted into a patient without causing much, if any, discomfort.
- the sensor body may have an outside diameter of about 150 microns or less, about 100 microns or less, about 75 microns or less, or even about 50 microns or less.
- a small volume of the bio-fluid sample e.g., blood, interstitial fluid, or other body fluid
- the bio-fluid sample e.g., blood, interstitial fluid, or other body fluid
- the required sample volume for an accurate reading may constitute less than about 0.4 microliters, less than about 0.3 microliters, or even less than about 0.2 microliters, for example. In some embodiments, the required sample volume may be less than about 0.1 microliters, or even less than about 0.05 microliters, for example.
- the active region of the lancet analyte sensor may include one or more catalytic agents and/or reagents adapted to react and convert an analyte in a received bio-fluid sample into reaction products from which an electrical current may be generated.
- the resulting electrical current may flow in the sensor body.
- the current may flow in the core and/or the cladding.
- the conductive material of the core and/or semiconductor material of the cladding may form at least a portion of a working electrode.
- the electrical current may then be detected, such as by a measurement or testing device (e.g., an ammeter) connected to the working electrode, thereby enabling a determination of an analyte concentration level in the bio-fluid sample.
- the electrical current may have a magnitude, which may be correlated with the concentration of the analyte in the bio-fluid sample, for example.
- FIG. 1A is a cross-sectional side view of an exemplary embodiment of a lancet analyte sensor 100 provided according to the present invention.
- the analyte sensor 100 may include a sensor body 102 , which may be approximately cylindrical in shape.
- the sensor body 102 may further comprise a semiconductor material.
- the body 102 may include a core 104 comprised of a conductive material.
- the core 104 may be at least partially surrounded by a cladding 106 , which may be comprised of the semiconductor material.
- the cladding 106 may include an annular shape and may fully surround the core 104 , which may comprise the shape of a cylindrical rod.
- Both the core 104 which may be comprised of a conductive material, and the cladding 106 , which may be comprised of semiconductor material, may convey electrical current, albeit the semiconductor material may have a higher resistivity as compared to the core 104 and may carry, therefore, less current than the core 104 .
- the core 104 may comprise carbon (e.g. graphite) and the cladding 106 may comprise silicon carbide (SiC).
- the sensor body may be provided in the form of a fiber (e.g., a SiC/C fiber).
- SiC/C fibers having a suitable SiC cladding and carbon core are manufactured by Specialty Materials Inc. of Lowell, Mass., for example.
- the conductive material of the core 104 may comprise other conductive materials including graphite, noble metals (e.g., platinum, tantalum, gold or silver) or other conductive metals (e.g., aluminum or copper).
- the cladding 106 may comprise other semiconductor materials including Group IV elements such as silicon and germanium, Group IV compounds such as silicon germanide (SiGe), and Group III-V compounds such as gallium arsenide (GaAs) and indium phosphide (InP), among others.
- Group IV elements such as silicon and germanium
- Group IV compounds such as silicon germanide (SiGe)
- Group III-V compounds such as gallium arsenide (GaAs) and indium phosphide (InP), among others.
- the sensor body 102 may have a total diameter D (including the core 104 and cladding 106 ) of about 150 microns or less, about 100 microns or less, about 75 microns or less, or even about 50 microns or less.
- the total diameter D may range between about 50 microns and about 150 microns in some embodiments (although larger or smaller sizes may also be used).
- the core 104 may have a diameter d between about 10 microns and about 100 microns, or even between about 20 microns and about 40 microns. In some embodiments, a diameter d of about 30 microns may be used, although other dimensions may also be used.
- the sensor body 102 may be fabricated and machined (e.g., by a laser) easily at small diameters (e.g., less than 150 microns).
- the high tensile strength of SiC of between about 3450 MPa to 5865 MPa may provide desirable strength to the sensor body 102 .
- the sensor body 102 having a SiC cladding 106 may have a modulus sufficient to provide flexibility for bending or deformation and ultimate strength sufficient to prevent breakage during insertion.
- the sensor body 102 may be cleaved at an angle at one end 108 (the ‘cleaved end’) to form a lancet 110 which can be readily inserted into a patient to obtain a bio-fluid sample (e.g., blood, interstitial fluid, or other bodily fluid).
- a bio-fluid sample e.g., blood, interstitial fluid, or other bodily fluid.
- Exemplary cleave angles ⁇ range from about 25 degrees to about 50 degrees, and are preferably about 35 degrees, although other angles may be used.
- the cleaved angle may be readily cut by a laser, which may provide a smooth surface finish.
- a cavity 112 may be provided proximate to the cleaved end 108 and the core 104 of the sensor body 102 .
- the cavity 112 may be formed, for example, by removing a portion of the material forming the core 104 to produce a hollowed out area.
- the cavity 112 may have a diameter equivalent to the diameter d of the core 104 (e.g., about 10 to about 100 microns).
- the diameter of the cavity may be larger or smaller than the core as well, and may be of irregular shape, such as oval or elongated (in a cross sectional view).
- the depth h of the cavity 112 may be between about 0.5 mm and about 5 mm, for example. Other cavity dimensions may be used.
- any suitable technique may be used to remove the core material to form the cavity 112 , such as machining, thermal oxidation (using a torch or laser), etching, plasma or corona discharge machining, or the like.
- the melting point of the conductive core 104 may be below that of the semiconductor cladding 106 thereby enabling preferential removal of core material without simultaneous removal of cladding material.
- a channel 114 may be formed in the cladding 106 at the cleaved end 108 proximate to the lancet 110 such as by deep reactive etching, for example.
- the channel 114 may be coupled directly to the cavity 112 . Accordingly, during usage, the channel 114 may be in fluid communication with the cavity 112 such that during an insertion of the lancet 110 into a patient, at least a portion of the sample bio-fluid contacting an area located around the lancet 110 may be drawn, such as by capillary action, into the channel 114 and/or may otherwise be guided into the cavity 112 .
- the channel 114 may have a width of about 10 microns to about 100 microns, and a depth of between about 10 microns to about 100 microns, although other dimensions may be used.
- the channel may be square or rectangular in cross section, and may have rounded corners, for example.
- FIG. 1B A perspective view of the sensor body 102 including the core 104 and cladding 106 and the cleaved end 108 of the sensor 100 is depicted in FIG. 1B .
- the channel 114 may be formed into the cleaved end 108 and intersects with the cavity 112 . More than one channel 114 may also be used. It is noted, however, that the small diameter of the cavity 112 may be sufficient by itself to induce capillary action for drawing a bio-sample into the cavity 112 without the aid of the channel 114 .
- a vent hole (not shown) may be provided in a side wall of the sensor body.
- a sufficient sample for purposes of detecting an analyte concentration level may have a volume of less than about 3 microliters, less than about 2 microliters, less than about 1 microliters, or even less than about 0.5 microliters.
- the relatively small diameter of the sensor body may provide for a sufficient sample volume being less than about 0.4 microliters, less than about 0.3 microliters, less than about 0.2 microliters, less than about 0.1 microliters, or even less than about 0.05 microliters, for example.
- a sufficient sample volume may, in some embodiments, range between about 0.05 microliters to about 3 microliters. Other sample volumes may also be employed.
- the combination of the small diameter of the sensor body 102 and the capillary action into the cavity 112 may reduce or eliminate much of the pain and discomfort associated with bio-fluid sample collection.
- an active region 116 may be positioned within the cavity 112 , and preferably at the bottom of the cavity, thereby allowing exposure of the active region to the sample bio-fluid that enters the cavity 112 (e.g., by capillary action).
- the active region 116 may also be positioned in an abutting and/or electrical contacting relationship with a working electrode 118 .
- the active region 116 may include one or more catalytic agents or reagents adapted to promote an electrochemical reaction between an analyte within the bio-fluid sample and the catalytic agents or reagents to produce reaction products and the flow of electrons.
- a portion of the working electrode 118 formed proximate to the core 104 may then channel the electron flow (e.g., through the core 104 and/or cladding 106 ) and provide an electrical current which may be proportional to the concentration of the analyte in the bio-fluid sample. This current may then be conditioned and displayed in any suitable readout form, such as in a digital readout of a test apparatus (e.g., such as shown in FIG. 3 ).
- oxidase enzymes which includes, for example, glucose oxidase (which converts glucose), lactate oxidase (which converts lactate), and D-aspartate oxidase (which converts D-aspartate and D-glutamate).
- glucose oxidase which converts glucose
- lactate oxidase which converts lactate
- D-aspartate oxidase which converts D-aspartate and D-glutamate
- glucose dehydrogenase GDH
- Pyrolloquinoline quinine (PQQ) or flavin adenine dinucleotide (FAD) dependent may also be used.
- the active region 116 may include one or more layers (not explicitly shown) in which the catalytic agents (e.g., enzymes) and/or other reagents may be immobilized or deposited.
- the one or more layers may comprise various polymers, for example, including silicone-based or organic polymers such as polyvinylpyrrolidone, polyvinylalcohol, polyethylene oxide, cellulosic polymers such as hydroxyethylcellulose or carboxymethyl cellulose, polyethylenes, polyurethanes, polypropylenes, polyterafluoroethylenes, block co-polymers, sol-gels, etc.
- a number of different techniques may be used to immobilize the enzymes in the one or more layers in the active region 116 including, but not limited to, coupling the enzymes to the lattice of a polymer matrix such as a sol gel, cross-linking the agents to a suitable matrix such as glutaraldehyde, electropolymerization or electroactive polymers, and formation of an array between the enzymes via covalent binding, or the like.
- a polymer matrix such as a sol gel
- suitable matrix such as glutaraldehyde, electropolymerization or electroactive polymers
- the working electrode 118 may be directly coupled to the active region 116 .
- a portion (e.g., an end surface or pocket) of the conductive core 104 in contact with the active region 116 may comprise the working electrode 118 .
- an electrochemically active layer (not explicitly shown) may be positioned adjacent to the end of the core 104 and/or cladding 106 to form the working electrode 118 .
- the electrochemically active layer may include, for example, noble metals such as platinum, palladium, gold or rhodium, or other suitable materials. In a glucose detection embodiment, the active layer may undergo a redox reaction with hydrogen peroxide when polarized appropriately.
- the redox reaction causes an electrical current to be generated at the working electrode 118 by electron transfer that is proportional to the concentration of the analyte that has been converted into hydrogen peroxide.
- This current may be conveyed from the electrochemically active layer 116 through the core 104 and/or cladding 106 to a testing or measurement device (e.g., such as shown in FIG. 3 ).
- mediators may be included in the active region 116 to promote the conversion of the analyte to detectable reaction products.
- Mediators comprise substances that act as intermediaries between the catalytic agent and the working electrode 118 .
- a mediator may promote electron transfer between the reaction center where catalytic breakdown of an analyte takes place and the working electrode 118 , and may enhance electrochemical activity at the working electrode 118 .
- Suitable mediators may include one or more of the following: metal complexes including ferrocene and its derivatives, ferrocyanide, phenothiazine derivatives, osmium complexes, quinines, phthalocyanines, organic dyes as well as other substances.
- the mediators may be cross-linked along with catalytic agents directly to the working electrode 118 .
- the analyte sensor 100 may also include a reference electrode 120 , which in one or more embodiments may also function as a counter electrode providing a return path for an electrical current.
- the reference electrode may be arranged, formed and/or implemented in a number of different ways.
- the reference electrode 120 may comprise Ag/AgCl or other suitable electrically conductive materials such as carbon, and may be formed as a coil (as shown), foil, film or the like.
- the reference electrode 120 may be coupled to the sensor 100 and may be surrounded by a sealing material 122 such as a flexible polymer (e.g., polycarbonate, polyethylene) which may be concentric with, and surround, at least a portion of the cladding 106 of the sensor body 102 .
- a sealing material 122 such as a flexible polymer (e.g., polycarbonate, polyethylene) which may be concentric with, and surround, at least a portion of the cladding 106 of the sensor body 102 .
- Confined within the sealing material 122 may be an electrolyte fluid 124 such as a viscous conductive liquid (e.g., a hydrogel) or other salt-containing solution.
- the surface of the cladding 106 may include an insulating layer of a non-permeable polymer (e.g., polyimide, polystyrene) to prevent an electrical pathway between the electrolyte fluid 124 and the cladding 106 .
- a non-permeable polymer e.g., polyimide, polystyrene
- the reference electrode 120 may be coupled to the electrolyte fluid 124 contained in the sealing material 122 .
- the active region 116 of the cavity 112 may be fluidly coupled to the electrolyte fluid 124 in the sealing material 122 via a conduit 126 .
- the surface area of the reference electrode 120 may be considerably larger than the surface area of the working electrode 118 to enhance conductivity, and in some embodiments, the surface area of the reference electrode 120 may be about 1000 times as large as a surface area of the working electrode 118 or larger. Other reference electrode sizes may also be used.
- An electrical circuit connection to the reference sensor electrode 120 may be made by any suitable means, such as a conductive strip (not shown) formed along a side of the sensor.
- a meter (M) may connect to the reference electrode 120 and the sensor body 102 and be used to read out an electrical current generated by the active region 116 .
- FIG. 2 is a cross-sectional view of a testing apparatus including another embodiment of a lancet analyte sensor 200 according to the present invention.
- a sensor body 202 which may have similar features to the sensor body 102 described with respect to FIG. 1A above, is integral with, and movably coupled to, a housing 213 .
- the sensor body 202 may be extended forwardly and retracted backwardly through a port 211 in the housing 213 (as indicated by the line 207 ).
- the sensor body 202 may be extended forwardly out of the housing 213 in order to insert the cleaved end 208 into the patient and collect a bio-fluid sample in the cavity 212 , and thereafter may be retracted backwardly into the housing 213 for post-sample analysis (e.g., current measurements).
- the sensor body 202 may be coupled to any suitable motion producing mechanism.
- a motive device 215 may cause relative movement between the housing 213 and sensor body 202 .
- the motive device 215 may be a spring whose energy may be released with a trigger mechanism, for example, or an actuator such as a linear motor or solenoid, which is adapted to effectuate such linear movement (e.g., extension and retraction).
- the motive device 215 may be electrically coupled to a working electrode 218 of the sensor body 202 , such that the motive device 215 receives an electrical signal when an analyte is detected in an active region 216 of the sensor 200 and a current is produced at the working electrode 218 .
- the motive device 215 may cause the sensor body 202 to retract into the housing 213 .
- the housing 213 may contain an electrolyte fluid 214 (an ‘electrolyte’) such as a salt-containing solution, a hydrogel, or the like.
- the senor 200 may be in fluid communication with the electrolyte 214 such that when the body 202 is retracted, the body 202 may be at least partially submerged in the electrolyte 214 within the housing 213 .
- the housing 213 may include a reference electrode 220 (e.g., an Ag/AgCl coil or foil or another suitable electrically conductive reference electrode material) positioned within the electrolyte fluid 214 and coupled to the sensor 200 .
- a reference electrode 220 e.g., an Ag/AgCl coil or foil or another suitable electrically conductive reference electrode material
- electrochemical activity at the working electrode 218 of the sensor 200 may be communicated via a core 204 and/or cladding 206 to the electrolyte fluid 214 and to the reference electrode 220 when the body 202 is retracted into the housing 213 (e.g., upon detection of the analyte).
- a current measurement device 219 such as an ammeter (labeled “M”), may be coupled to the reference electrode 220 and working electrode 218 to measure the electrical activity representative of the analyte concentration in the active region 216 of the lancet analyte sensor 200 .
- FIG. 3 is a partial cross-sectional view of another embodiment of a lancet analyte sensor 300 according to the present invention.
- a reference electrode 320 may be at least partially positioned in a cavity 312 of the lancet sensor 300 where the bio-fluid sample may be received.
- the electrode 320 may be affixed or otherwise coupled to the cladding 306 , for example.
- the reference electrode 320 may be configured as a coil (e.g., of Ag/AgCl or another suitable electrically conductive material).
- the cavity 312 may be enlarged to accommodate a length of the reference electrode 320 .
- the reference electrode 320 and an active region 316 and working electrode 318 of the lancet sensor 300 is avoided to ensure proper performance of the lancet sensor 300 .
- This may be achieved, for example, by affixing the reference electrode 320 to an interior surface of the cavity 312 while maintaining the reference electrode 320 a clearance distance above the active region 316 .
- a suitable electrical connection to the reference sensor may be made along a side of the sensor 300 (not shown).
- the sensor 300 may include a cleaved end 308 formed on the cladding 306 to form an integral lancet 310 and may similarly include a capillary channel 314 .
- the lancet analyte sensor 300 is shown inserted into a port 330 of a testing apparatus 335 .
- an electrical contact comes into direct contact with the core 304 and/or cladding 306 .
- an analyte level proportional to the current in the core 304 and/or cladding 306 may be determined and may be displayed on a suitable digital display 340 , for example.
- FIG. 4 is a cross-sectional view of another embodiment of a lancet analyte sensor 400 according to the present invention.
- the lancet sensor 400 may include a sensor body 402 including a core 404 including a conductive material surrounded by a cladding 406 including a semiconductor material.
- a cavity 412 may be formed in the cladding 406 and may be included proximate the core 404 .
- a lancet 410 may be provided by forming a cleaved end 408 on the sensor 400 as in the previous embodiments. Additionally included in this embodiment may be an insulating layer 409 surrounding the cladding 406 .
- the core 404 may comprise carbon material (e.g., graphite) and the cladding 406 may comprise silicon carbide (SiC) although other materials may also be used (as described previously).
- the cladding 406 may further comprise a combination of silicon carbide and silicon nitride (SiC/Si 3 N 4 ) and/or any other suitable semiconductor material.
- the insulating layer 409 may comprise any suitable dielectric material, such as a polymer.
- the thickness of the insulating layer 409 should be between about 5 microns and about 100 microns, for example. Other thicknesses may be used.
- Surrounding the insulating layer 409 may be a reference electrode 420 of a conducting material such as Ag/AgCl or a noble metal (e.g., gold, silver, platinum, palladium or the like).
- a suitable thickness for the reference electrode 420 may be between about 10 microns and about 100 microns, for example.
- Some embodiments may include a thickness of the insulating layer 409 of between about 30 and 70 microns, and a thickness of the reference electrode 420 of between about 10 and 30 microns.
- the lancet sensor body 402 may be constructed by first removing carbon material from the core region near the cleaved end 408 of a SiC/C fiber by suitable techniques (as described above), to form the cavity 412 and then forming the insulating layer 409 over the cladding 406 .
- the cavity 412 may then have applied therein an active region 416 .
- the active region 416 may include, as described in the previous embodiments, one or more catalytic agents adapted to promote an electrochemical reaction of the analyte into reaction products which produces electron flow in a working electrode 418 formed at an upper surface of the core 404 within the cavity 412 .
- the core 404 may form a portion of the working electrode 418 with or without an additional active layer (e.g., platinum).
- the cladding 406 may form a portion of the working electrode as well.
- a reference electrode 420 may be coupled to the outer peripheral surface of the sensor 400 by placement directly in contact with the insulating layer 409 , for example.
- the reference electrode 420 may be made from Ag/AgCl layer or strip, a platinum film, and/or other suitable electrically conductive materials.
- FIG. 5 is a cross-sectional view of another embodiment of a test apparatus including another embodiment of a lancet analyte sensor 500 .
- the lancet analyte sensor 500 and the reference electrode 520 may be mounted in a housing 513 .
- the housing 513 may contain an electrolytic fluid 514 such as a hydrogel, and the sensor 500 and the reference electrode 520 may be positioned within, and coupled to each other by, the electrolytic fluid 514 .
- the lancet analyte sensor 500 may be extendable through a port 511 in the housing 513 for the purposes of taking a bio-fluid sample, and then may be retractable back into the port 511 as illustrated by line 507 .
- the senor 500 may be used for sample collection, it may have a cleaved end 508 formed on the cladding 506 as described above, while the reference electrode 520 need not be used for sample collection, and therefore it need not have a cleaved end.
- the sensor 500 may have a cavity 512 for receiving a bio-fluid sample containing an analyte, an active region 516 coupled to the cavity 512 including one or more catalytic agents or reagents, and a working electrode 518 coupled to the active region 516 .
- the working electrode 518 may comprise a portion of the core 504 and or cladding 506 of the sensor 500 , such as the end surface, which is exposed to the active region 516 .
- the reference electrode 520 need not have a cavity 512 , and rather, the end of the conductive core 521 may be directly exposed to the electrolytic fluid 514 in the housing 513 .
- the exposed core 521 may act as a reference electrode 520 adapted to detect charge carriers introduced into the electrolytic fluid 514 from the active region 516 of sensor 500 because of the sensor's contact with the fluid 514 .
- FIG. 6 depicts a cross-sectional view of another embodiment of a lancet analyte sensor 600 according to the present invention.
- the lancet sensor 600 may comprise a core 604 of a conductive material surrounded by a cladding 606 of a semiconductor material wherein a cavity 612 may be formed in the cladding and included proximate the core 604 .
- a lancet 610 may be provided by forming a cleaved end 608 on the sensor 600 , as in the previous embodiments.
- the core 604 and the cladding 606 may be manufactured from the materials as described previously.
- a reference electrode 620 may be coupled to the sensor 600 such as by being provided in the cavity 612 for example, similarly as described with reference to FIG. 3 .
- the core 604 may further include a pocket 613 formed therein which may form part of the cavity 612 .
- An active region 616 may be applied in the pocket 613 .
- the pocket 613 may include a conductive material (e.g., graphite) along its sides, an effective contact area of the active region 616 in contact with the core 604 may be enlarged.
- FIG. 7A and FIG. 7B depict cross-sectional and frontal views, respectively, of another embodiment of a lancet analyte sensor 700 according to the present invention.
- the lancet sensor 700 comprises a core 704 comprised of a conductive material which may be surrounded by a cladding 706 comprised of a semiconductor material.
- a cavity 712 may be formed in the cladding 706 and may be provided proximate the core 704 .
- a lancet 710 may be provided by forming a cleaved end 708 on the cladding 706 and core 704 .
- the core 704 and the cladding 706 may be manufactured from the materials described previously.
- the cavity 712 may be formed in the cladding 706 and the hollowed out area may be defined by the side walls of the cladding 706 .
- a channel 714 may be provided along the side of the cladding 706 to aid in the flow of a bio-fluid sample into the cavity 712 .
- An active region 716 may be positioned in the cavity 712 .
- the cavity 712 may be any shape such as round, oval, or elongated, and may extend laterally from the surface of the cladding 706 to intersect with the core 704 at a bottom of the cavity 712 .
- Providing the cavity 712 along a side surface of the lancet analyte sensor 700 may minimize blockage of the cavity 712 by perforated bio-material (e.g., skin) as compared to when the cavity is located at an end of the sensor. Additional cavities (not shown) may be provided along the side such that additional analytes may be tested.
- perforated bio-material e.g., skin
- FIG. 8 is a cross-sectional view of an additional embodiment of a lancet analyte sensor 800 according to the present invention.
- the lancet sensor 800 may comprise a sensor body 802 which may have a core 804 comprised of a conductive material surrounded by a cladding 806 comprised of a semiconductor material.
- a cavity 812 may be formed proximate the core 804 .
- the cavity 812 may be at least partially formed by inner walls of a separate lancet member 817 which may be coupled to the sensor body 802 by a suitable coupler 821 (e.g., by a section of tubing).
- the lancet member 817 may include an end having a portion that is separated from the body 802 or cleaved at an angle thereby forming an enlarged portion in the cavity adjacent to the core 804 .
- the enlarged portion may allow additional area for applying the active region 816 .
- the lancet member 817 may be formed of a hollow SiC fiber or other tubing material, such as stainless steel (e.g., an austenitic stainless steel).
- An exemplary length of the lancet member 817 may be about 2 microns to about 5 microns, although other lengths may be used.
- a lancet 810 may be provided by forming a cleaved end 808 on the lancet member 817 .
- the core 804 and the cladding 806 may be manufactured from the same materials described previously.
- the active region 816 may be positioned in the cavity 812 in contact with the core 804 .
- a reference sensor may be provided on the sensor body 802 , for example.
- FIG. 9 illustrates another embodiment of lancet analyte sensor 900 similar to the sensor of FIG. 8 , except that it further includes a reference sensor 920 positioned at the end of, and coupled to, the sensor body 902 . Additionally, in some embodiments, the coupler 921 include at least one vent hole 922 .
- FIG. 10 illustrates an apparatus including an array of sensors 1000 .
- the sensors 1000 may be arranged in any configuration, such as in a row or in any three dimensional arrangement (e.g., in a random or ordered pattern).
- the overall signal level may be enhanced, such as for continuous monitoring, for example.
- Any of the embodiments of sensors previously described may be incorporated into the array, such as those described with reference to FIG. 1A through FIG. 9 .
- the present invention provides a method of manufacturing an analyte sensor, including providing a fiber comprised of a semiconductor material; forming a cavity proximate to the fiber, applying an active region in the cavity, and forming lancet on the analyte sensor.
- FIG. 11 illustrates a method of manufacturing an analyte sensor according to the present invention.
- the method 1100 includes a step 1102 wherein the fiber is provided including a semiconductor material.
- the fiber may be a SiC/C fiber as discussed above.
- the fiber is provided cut to the appropriate length.
- a cavity may then be formed proximate the fiber in step 1104 . This may be by removal of a portion of the core, by the formation of a cavity in a side wall of the fiber, or by the attachment of a separate lancet member.
- An active region may be applied in contact with the fiber and in the cavity in step 1106 by methods described above.
- a lancet may be formed on the analyte sensor.
- the steps may not be provided in the order shown.
- the step of lancet formation in step 1108 may take place during the cutting operation.
- the step of forming a cavity in step 1104 may be accomplished after the application of the active region, for example by adding a separate lancet member.
- the step of forming the active region in the cavity may not occur until the attachment of a separate lancet member.
Abstract
In some aspects, an analyte sensor is provided for obtaining and detecting an analyte concentration level in a bio-fluid sample. The analyte sensor has a sensor body including a semiconductor material, an active region coupled to the sensor body, and a lancet provided on the analyte sensor. The conductor may include a fiber having a core of a conductive material and a semiconductor cladding surrounding the core. Numerous other aspects are provided.
Description
- This is a continuation of U.S. patent application Ser. No. 13/119,344, now U.S. Pat. No. x,xxx,xxx, filed Mar. 16, 2011 and titled “LANCET ANALYTE SENSORS AND METHODS OF MANUFACTURING” (Attorney Docket No. BHDD/002), which claims priority to and is a 371 application of International Application No. PCT/US2009/057253, filed Sep. 17, 2009, titled “LANCET ANALYTE SENSORS AND METHODS OF MANUFACTURING” which claims the benefit of U.S. Provisional Patent Application No. 61/098,714, filed Sep. 19, 2008 and titled “LANCET ANALYTE SENSORS AND METHODS OF MANUFACTURING” (Attorney Docket No. BHDD/002/L), all of which are hereby incorporated by reference herein in their entireties for all purposes.
- The present invention relates to electrochemical analyte sensors that may be used to detect an analyte concentration level in a bio-fluid sample taken from a patient.
- The monitoring of analyte concentration levels in a bio-fluid may be an important part of health diagnostics. For example, an electrochemical analyte sensor may be employed for the monitoring of a patient's blood glucose level as part of diabetes treatment and care.
- An electrochemical analyte sensor may be employed discretely (‘discrete monitoring’), for instance, by detecting an analyte concentration level in a single sample of blood or other interstitial fluid obtained from the patient by a lancet (e.g., by a pin-prick or needle). Optionally, the analyte sensor may be employed continuously (‘continuous monitoring’), by implanting a sensor in the patient for a duration of time. In discrete monitoring, there may be a separation between the sample collection process and the measurement of the analyte concentration level. Typically, after a bio-fluid sample has been obtained from the patient, such as by the use of a lancet, the sample may then be transferred to a medium (e.g., a test strip or a detector) for measurement of the sample's analyte concentration level.
- Conventional lancets, if too large, may cause undue pain and discomfort to the patient when inserted. Further, because conventional electrochemical analyte sensors may be of relatively low sensitivity and transfer of a bio-fluid sample to the sensor may be relatively inefficient, a relatively large sample volume may be required in order to yield an accurate measurement of the analyte concentration level. In such instances, if the sample provided is too small, the sensor may be provided with an insufficient sample volume for an accurate reading. Thus, additional bio-fluid may need to be drawn from the patient. Consequently, lancet insertion may need to be repeated, causing further patient pain and discomfort.
- It would therefore be beneficial to provide an analyte sensor adapted for bio-fluid analyte monitoring that is minimally invasive during sample collection, and yet consistently and readily provides for accurate analyte concentration level measurements from the obtained bio-fluid sample.
- In an aspect, the present invention provides an analyte sensor, including a sensor body comprised of a semiconductor material; an active region coupled to the sensor body; and a lancet formed on an end of the analyte sensor.
- In another aspect, the present invention provides an analyte sensor for detecting an analyte concentration level in a bio-fluid sample, including a core comprised of a conductive material; a cladding comprised of a semiconductor material surrounding the core; a cavity formed proximate to the core, and an active region provided within the cavity.
- In another aspect, the present invention provides an analyte sensor for detecting an analyte concentration level in a bio-fluid sample, including a fiber comprised of a semiconductor material; an active region in contact with the fiber, and a lancet formed on the analyte sensor.
- In another aspect, the present invention provides a testing apparatus, including an analyte sensor having a sensor body comprised of a semiconductor material; an active region coupled to the sensor body; and a lancet formed on an end of the analyte sensor.
- In a method aspect, the present invention provides a method of manufacturing an analyte sensor, including providing a fiber comprised of a semiconductor material; forming a cavity proximate to the fiber, forming an active region in the cavity, and forming lancet on the analyte sensor.
- Other features and aspects of the present invention will become more fully apparent from the following detailed description, the appended claims and the accompanying drawings.
-
FIG. 1A is a cross-sectional view of an exemplary embodiment of an analyte sensor provided according to the present invention. -
FIG. 1B is a perspective view of the analyte sensor according to the exemplary embodiment shown inFIG. 1A . -
FIG. 2 is a cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 3 is a partial cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 4 is a cross-sectional view of another exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 5 is a cross-sectional view of an apparatus including another exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 6 is a cross-sectional view of an additional exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 7A is a cross-sectional view of an additional exemplary embodiment of an analyte sensor according to the present invention. -
FIG. 7B is a frontal view of the exemplary embodiment of the analyte sensor ofFIG. 7A . -
FIGS. 8 and 9 are cross-sectional views of additional exemplary embodiments of analyte sensors according to the present invention. -
FIG. 10 is a frontal view of an apparatus including an array of analyte sensors according to the present invention. -
FIG. 11 is a flowchart illustrating a method of manufacturing lancet analyte sensors according to the present invention. - According to a first aspect of the present invention, a lancet analyte sensor is provided that integrates the functions of a lancet and an analyte sensor into a single device. In this manner, the processes of sample collection and analyte detection may be performed without the need to transfer the sample to a transfer medium, such as an analyte sensor strip or an external detection or testing device.
- An exemplary lancet analyte sensor (hereinafter otherwise referred to as an “analyte sensor” or simply a “sensor”) may include a sensor body comprised of a semiconductor material. The sensor body in some embodiments may include a core including a conductive material and a cladding. In some embodiments, the conductive core of the analyte sensor may comprise carbon (e.g., graphite) and the semiconductor cladding may comprise silicon carbide.
- In one or more embodiments, a lancet may be formed on the analyte sensor. Lancet is defined herein as a sharpened area or point that is provided on an end of the lancet analyte sensor. For example, in some embodiments, a cladding of the conductor may be cleaved at an angle at one end to provide a lancet for insertion. Optionally, the lancet may be a separate member and may be otherwise coupled to the sensor body, such as to the cladding for example.
- Further, the analyte sensor may include a cavity located proximate to the sensor body (e.g., proximate the core) for accepting the bio-fluid sample. The term “cavity” as defined herein is a hollow, indented, or concave area having walls adapted to contain and confine the bio-fluid sample. In some embodiments, the cavity may be at least partially surrounded by the cladding whereby the walls of the cavity are formed by the cladding material (e.g., by an inner surface of the cladding). In other embodiments, the cavity is at least partially formed by walls of a lancet member connected to the sensor body. In further embodiments, the cavity may be formed in a peripheral side wall of the sensor body. Furthermore, the cavity may be provided with an active region which may be coupled to the core and/or cladding and may be adapted to generate an electrical current which may be proportional to an analyte concentration level.
- The diameter of the lancet analyte sensor may be smaller than conventional lancets, such that the lancet analyte sensor may be inserted into a patient without causing much, if any, discomfort. For example, the sensor body may have an outside diameter of about 150 microns or less, about 100 microns or less, about 75 microns or less, or even about 50 microns or less. Upon insertion, a small volume of the bio-fluid sample (e.g., blood, interstitial fluid, or other body fluid) may be guided into the cavity of the sensor, such as by capillary action for example. The required sample volume for an accurate reading may constitute less than about 0.4 microliters, less than about 0.3 microliters, or even less than about 0.2 microliters, for example. In some embodiments, the required sample volume may be less than about 0.1 microliters, or even less than about 0.05 microliters, for example.
- The active region of the lancet analyte sensor may include one or more catalytic agents and/or reagents adapted to react and convert an analyte in a received bio-fluid sample into reaction products from which an electrical current may be generated. The resulting electrical current may flow in the sensor body. For example, the current may flow in the core and/or the cladding. Thus, in some embodiments, the conductive material of the core and/or semiconductor material of the cladding may form at least a portion of a working electrode. The electrical current may then be detected, such as by a measurement or testing device (e.g., an ammeter) connected to the working electrode, thereby enabling a determination of an analyte concentration level in the bio-fluid sample.
- In operation, the electrical current may have a magnitude, which may be correlated with the concentration of the analyte in the bio-fluid sample, for example. These and other embodiments of the analyte sensors of the present invention are described below with reference to
FIGS. 1A-10 . -
FIG. 1A is a cross-sectional side view of an exemplary embodiment of alancet analyte sensor 100 provided according to the present invention. Theanalyte sensor 100 may include asensor body 102, which may be approximately cylindrical in shape. Thesensor body 102 may further comprise a semiconductor material. In particular, thebody 102 may include acore 104 comprised of a conductive material. Thecore 104 may be at least partially surrounded by acladding 106, which may be comprised of the semiconductor material. In the exemplary embodiment shown, thecladding 106 may include an annular shape and may fully surround thecore 104, which may comprise the shape of a cylindrical rod. Both thecore 104, which may be comprised of a conductive material, and thecladding 106, which may be comprised of semiconductor material, may convey electrical current, albeit the semiconductor material may have a higher resistivity as compared to thecore 104 and may carry, therefore, less current than thecore 104. In some embodiments, thecore 104 may comprise carbon (e.g. graphite) and thecladding 106 may comprise silicon carbide (SiC). - In some embodiments, the sensor body may be provided in the form of a fiber (e.g., a SiC/C fiber). SiC/C fibers having a suitable SiC cladding and carbon core are manufactured by Specialty Materials Inc. of Lowell, Mass., for example. However, the conductive material of the
core 104 may comprise other conductive materials including graphite, noble metals (e.g., platinum, tantalum, gold or silver) or other conductive metals (e.g., aluminum or copper). Thecladding 106 may comprise other semiconductor materials including Group IV elements such as silicon and germanium, Group IV compounds such as silicon germanide (SiGe), and Group III-V compounds such as gallium arsenide (GaAs) and indium phosphide (InP), among others. - Furthermore, in some embodiments the
sensor body 102 may have a total diameter D (including thecore 104 and cladding 106) of about 150 microns or less, about 100 microns or less, about 75 microns or less, or even about 50 microns or less. The total diameter D may range between about 50 microns and about 150 microns in some embodiments (although larger or smaller sizes may also be used). Thecore 104 may have a diameter d between about 10 microns and about 100 microns, or even between about 20 microns and about 40 microns. In some embodiments, a diameter d of about 30 microns may be used, although other dimensions may also be used. In embodiments in which aSiC cladding 106 is used, thesensor body 102 may be fabricated and machined (e.g., by a laser) easily at small diameters (e.g., less than 150 microns). In addition, the high tensile strength of SiC of between about 3450 MPa to 5865 MPa may provide desirable strength to thesensor body 102. Moreover, even at this reduced diameter, thesensor body 102 having aSiC cladding 106 may have a modulus sufficient to provide flexibility for bending or deformation and ultimate strength sufficient to prevent breakage during insertion. - The
sensor body 102 may be cleaved at an angle at one end 108 (the ‘cleaved end’) to form alancet 110 which can be readily inserted into a patient to obtain a bio-fluid sample (e.g., blood, interstitial fluid, or other bodily fluid). Exemplary cleave angles θ range from about 25 degrees to about 50 degrees, and are preferably about 35 degrees, although other angles may be used. The cleaved angle may be readily cut by a laser, which may provide a smooth surface finish. - Located proximate to the
cleaved end 108 and thecore 104 of thesensor body 102, acavity 112 may be provided. Thecavity 112 may be formed, for example, by removing a portion of the material forming the core 104 to produce a hollowed out area. In some embodiments, thecavity 112 may have a diameter equivalent to the diameter d of the core 104 (e.g., about 10 to about 100 microns). However, the diameter of the cavity may be larger or smaller than the core as well, and may be of irregular shape, such as oval or elongated (in a cross sectional view). The depth h of thecavity 112 may be between about 0.5 mm and about 5 mm, for example. Other cavity dimensions may be used. - Any suitable technique may be used to remove the core material to form the
cavity 112, such as machining, thermal oxidation (using a torch or laser), etching, plasma or corona discharge machining, or the like. In some embodiments, the melting point of theconductive core 104 may be below that of thesemiconductor cladding 106 thereby enabling preferential removal of core material without simultaneous removal of cladding material. - In some embodiments, a
channel 114 may be formed in thecladding 106 at thecleaved end 108 proximate to thelancet 110 such as by deep reactive etching, for example. Thechannel 114 may be coupled directly to thecavity 112. Accordingly, during usage, thechannel 114 may be in fluid communication with thecavity 112 such that during an insertion of thelancet 110 into a patient, at least a portion of the sample bio-fluid contacting an area located around thelancet 110 may be drawn, such as by capillary action, into thechannel 114 and/or may otherwise be guided into thecavity 112. In some embodiments, thechannel 114 may have a width of about 10 microns to about 100 microns, and a depth of between about 10 microns to about 100 microns, although other dimensions may be used. The channel may be square or rectangular in cross section, and may have rounded corners, for example. - A perspective view of the
sensor body 102 including thecore 104 andcladding 106 and thecleaved end 108 of thesensor 100 is depicted inFIG. 1B . As illustrated, thechannel 114 may be formed into thecleaved end 108 and intersects with thecavity 112. More than onechannel 114 may also be used. It is noted, however, that the small diameter of thecavity 112 may be sufficient by itself to induce capillary action for drawing a bio-sample into thecavity 112 without the aid of thechannel 114. Optionally a vent hole (not shown) may be provided in a side wall of the sensor body. In some embodiments, a sufficient sample for purposes of detecting an analyte concentration level may have a volume of less than about 3 microliters, less than about 2 microliters, less than about 1 microliters, or even less than about 0.5 microliters. In further exemplary embodiments, the relatively small diameter of the sensor body may provide for a sufficient sample volume being less than about 0.4 microliters, less than about 0.3 microliters, less than about 0.2 microliters, less than about 0.1 microliters, or even less than about 0.05 microliters, for example. A sufficient sample volume may, in some embodiments, range between about 0.05 microliters to about 3 microliters. Other sample volumes may also be employed. The combination of the small diameter of thesensor body 102 and the capillary action into thecavity 112 may reduce or eliminate much of the pain and discomfort associated with bio-fluid sample collection. - Again referring to
FIG. 1A , anactive region 116 may be positioned within thecavity 112, and preferably at the bottom of the cavity, thereby allowing exposure of the active region to the sample bio-fluid that enters the cavity 112 (e.g., by capillary action). Theactive region 116 may also be positioned in an abutting and/or electrical contacting relationship with a workingelectrode 118. Theactive region 116 may include one or more catalytic agents or reagents adapted to promote an electrochemical reaction between an analyte within the bio-fluid sample and the catalytic agents or reagents to produce reaction products and the flow of electrons. A portion of the workingelectrode 118 formed proximate to thecore 104 may then channel the electron flow (e.g., through thecore 104 and/or cladding 106) and provide an electrical current which may be proportional to the concentration of the analyte in the bio-fluid sample. This current may then be conditioned and displayed in any suitable readout form, such as in a digital readout of a test apparatus (e.g., such as shown inFIG. 3 ). - One group of catalytic agents useful within the
active region 116 is the class of oxidase enzymes which includes, for example, glucose oxidase (which converts glucose), lactate oxidase (which converts lactate), and D-aspartate oxidase (which converts D-aspartate and D-glutamate). In embodiments in which glucose is the analyte of interest, glucose dehydrogenase (GDH) may optionally be used. Pyrolloquinoline quinine (PQQ) or flavin adenine dinucleotide (FAD) dependent may also be used. A more detailed list of oxidase enzymes which may be employed in the present invention is provided in U.S. Pat. No. 4,721,677, entitled “Implantable Gas-containing Biosensor and Method for Measuring an Analyte such as Glucose” to Clark Jr. which is hereby incorporated by reference herein in its entirety. Catalytic enzymes other than oxidase enzymes may also be used. - The
active region 116 may include one or more layers (not explicitly shown) in which the catalytic agents (e.g., enzymes) and/or other reagents may be immobilized or deposited. The one or more layers may comprise various polymers, for example, including silicone-based or organic polymers such as polyvinylpyrrolidone, polyvinylalcohol, polyethylene oxide, cellulosic polymers such as hydroxyethylcellulose or carboxymethyl cellulose, polyethylenes, polyurethanes, polypropylenes, polyterafluoroethylenes, block co-polymers, sol-gels, etc. A number of different techniques may be used to immobilize the enzymes in the one or more layers in theactive region 116 including, but not limited to, coupling the enzymes to the lattice of a polymer matrix such as a sol gel, cross-linking the agents to a suitable matrix such as glutaraldehyde, electropolymerization or electroactive polymers, and formation of an array between the enzymes via covalent binding, or the like. - In one or more embodiments, the working
electrode 118 may be directly coupled to theactive region 116. In some embodiments, a portion (e.g., an end surface or pocket) of theconductive core 104 in contact with theactive region 116 may comprise the workingelectrode 118. In other embodiments, an electrochemically active layer (not explicitly shown) may be positioned adjacent to the end of thecore 104 and/orcladding 106 to form the workingelectrode 118. The electrochemically active layer may include, for example, noble metals such as platinum, palladium, gold or rhodium, or other suitable materials. In a glucose detection embodiment, the active layer may undergo a redox reaction with hydrogen peroxide when polarized appropriately. The redox reaction causes an electrical current to be generated at the workingelectrode 118 by electron transfer that is proportional to the concentration of the analyte that has been converted into hydrogen peroxide. This current may be conveyed from the electrochemicallyactive layer 116 through thecore 104 and/orcladding 106 to a testing or measurement device (e.g., such as shown inFIG. 3 ). - Additionally, in some embodiments of the invention, mediators may be included in the
active region 116 to promote the conversion of the analyte to detectable reaction products. Mediators comprise substances that act as intermediaries between the catalytic agent and the workingelectrode 118. For example, a mediator may promote electron transfer between the reaction center where catalytic breakdown of an analyte takes place and the workingelectrode 118, and may enhance electrochemical activity at the workingelectrode 118. Suitable mediators may include one or more of the following: metal complexes including ferrocene and its derivatives, ferrocyanide, phenothiazine derivatives, osmium complexes, quinines, phthalocyanines, organic dyes as well as other substances. In some embodiments, the mediators may be cross-linked along with catalytic agents directly to the workingelectrode 118. - The
analyte sensor 100 may also include areference electrode 120, which in one or more embodiments may also function as a counter electrode providing a return path for an electrical current. As described further with reference toFIGS. 1A to 10 , the reference electrode may be arranged, formed and/or implemented in a number of different ways. In the embodiment depicted inFIG. 1A , thereference electrode 120 may comprise Ag/AgCl or other suitable electrically conductive materials such as carbon, and may be formed as a coil (as shown), foil, film or the like. In the depicted embodiment, thereference electrode 120 may be coupled to thesensor 100 and may be surrounded by a sealingmaterial 122 such as a flexible polymer (e.g., polycarbonate, polyethylene) which may be concentric with, and surround, at least a portion of thecladding 106 of thesensor body 102. Confined within the sealingmaterial 122 may be anelectrolyte fluid 124 such as a viscous conductive liquid (e.g., a hydrogel) or other salt-containing solution. In some embodiments, the surface of thecladding 106 may include an insulating layer of a non-permeable polymer (e.g., polyimide, polystyrene) to prevent an electrical pathway between theelectrolyte fluid 124 and thecladding 106. - To form an electrochemical cell, the
reference electrode 120 may be coupled to theelectrolyte fluid 124 contained in the sealingmaterial 122. Likewise, theactive region 116 of thecavity 112 may be fluidly coupled to theelectrolyte fluid 124 in the sealingmaterial 122 via aconduit 126. The surface area of thereference electrode 120 may be considerably larger than the surface area of the workingelectrode 118 to enhance conductivity, and in some embodiments, the surface area of thereference electrode 120 may be about 1000 times as large as a surface area of the workingelectrode 118 or larger. Other reference electrode sizes may also be used. An electrical circuit connection to thereference sensor electrode 120 may be made by any suitable means, such as a conductive strip (not shown) formed along a side of the sensor. Thus, a meter (M) may connect to thereference electrode 120 and thesensor body 102 and be used to read out an electrical current generated by theactive region 116. -
FIG. 2 is a cross-sectional view of a testing apparatus including another embodiment of alancet analyte sensor 200 according to the present invention. In this embodiment, asensor body 202, which may have similar features to thesensor body 102 described with respect toFIG. 1A above, is integral with, and movably coupled to, ahousing 213. For example, thesensor body 202 may be extended forwardly and retracted backwardly through aport 211 in the housing 213 (as indicated by the line 207). In some embodiments, thesensor body 202 may be extended forwardly out of thehousing 213 in order to insert thecleaved end 208 into the patient and collect a bio-fluid sample in thecavity 212, and thereafter may be retracted backwardly into thehousing 213 for post-sample analysis (e.g., current measurements). Thesensor body 202 may be coupled to any suitable motion producing mechanism. For example, amotive device 215 may cause relative movement between thehousing 213 andsensor body 202. Themotive device 215 may be a spring whose energy may be released with a trigger mechanism, for example, or an actuator such as a linear motor or solenoid, which is adapted to effectuate such linear movement (e.g., extension and retraction). - In some embodiments, the
motive device 215 may be electrically coupled to a workingelectrode 218 of thesensor body 202, such that themotive device 215 receives an electrical signal when an analyte is detected in anactive region 216 of thesensor 200 and a current is produced at the workingelectrode 218. In one or more embodiments, upon receipt of the current signal, themotive device 215 may cause thesensor body 202 to retract into thehousing 213. Thehousing 213 may contain an electrolyte fluid 214 (an ‘electrolyte’) such as a salt-containing solution, a hydrogel, or the like. - In operation, the
sensor 200 may be in fluid communication with theelectrolyte 214 such that when thebody 202 is retracted, thebody 202 may be at least partially submerged in theelectrolyte 214 within thehousing 213. Thehousing 213 may include a reference electrode 220 (e.g., an Ag/AgCl coil or foil or another suitable electrically conductive reference electrode material) positioned within theelectrolyte fluid 214 and coupled to thesensor 200. In this embodiment, electrochemical activity at the workingelectrode 218 of thesensor 200 may be communicated via acore 204 and/orcladding 206 to theelectrolyte fluid 214 and to thereference electrode 220 when thebody 202 is retracted into the housing 213 (e.g., upon detection of the analyte). Acurrent measurement device 219, such as an ammeter (labeled “M”), may be coupled to thereference electrode 220 and workingelectrode 218 to measure the electrical activity representative of the analyte concentration in theactive region 216 of thelancet analyte sensor 200. -
FIG. 3 is a partial cross-sectional view of another embodiment of alancet analyte sensor 300 according to the present invention. In the embodiment depicted inFIG. 3 , areference electrode 320 may be at least partially positioned in acavity 312 of thelancet sensor 300 where the bio-fluid sample may be received. Theelectrode 320 may be affixed or otherwise coupled to thecladding 306, for example. In the illustrated embodiment, thereference electrode 320 may be configured as a coil (e.g., of Ag/AgCl or another suitable electrically conductive material). Thecavity 312 may be enlarged to accommodate a length of thereference electrode 320. - In the illustrated embodiment, contact between the
reference electrode 320 and anactive region 316 and workingelectrode 318 of thelancet sensor 300 is avoided to ensure proper performance of thelancet sensor 300. This may be achieved, for example, by affixing thereference electrode 320 to an interior surface of thecavity 312 while maintaining the reference electrode 320 a clearance distance above theactive region 316. A suitable electrical connection to the reference sensor may be made along a side of the sensor 300 (not shown). As in the prior embodiments, thesensor 300 may include acleaved end 308 formed on thecladding 306 to form anintegral lancet 310 and may similarly include acapillary channel 314. In the depicted embodiment, thelancet analyte sensor 300 is shown inserted into aport 330 of atesting apparatus 335. Upon insertion into thetesting apparatus 335, an electrical contact comes into direct contact with thecore 304 and/orcladding 306. Accordingly, an analyte level proportional to the current in thecore 304 and/orcladding 306 may be determined and may be displayed on a suitabledigital display 340, for example. -
FIG. 4 is a cross-sectional view of another embodiment of alancet analyte sensor 400 according to the present invention. Thelancet sensor 400 may include asensor body 402 including acore 404 including a conductive material surrounded by acladding 406 including a semiconductor material. In the depicted embodiment, acavity 412 may be formed in thecladding 406 and may be included proximate thecore 404. Alancet 410 may be provided by forming acleaved end 408 on thesensor 400 as in the previous embodiments. Additionally included in this embodiment may be an insulatinglayer 409 surrounding thecladding 406. In some embodiments, thecore 404 may comprise carbon material (e.g., graphite) and thecladding 406 may comprise silicon carbide (SiC) although other materials may also be used (as described previously). Thecladding 406 may further comprise a combination of silicon carbide and silicon nitride (SiC/Si3N4) and/or any other suitable semiconductor material. - The insulating
layer 409 may comprise any suitable dielectric material, such as a polymer. The thickness of the insulatinglayer 409 should be between about 5 microns and about 100 microns, for example. Other thicknesses may be used. Surrounding the insulatinglayer 409 may be areference electrode 420 of a conducting material such as Ag/AgCl or a noble metal (e.g., gold, silver, platinum, palladium or the like). A suitable thickness for thereference electrode 420 may be between about 10 microns and about 100 microns, for example. Some embodiments may include a thickness of the insulatinglayer 409 of between about 30 and 70 microns, and a thickness of thereference electrode 420 of between about 10 and 30 microns. - In one or more embodiments of the present invention, the
lancet sensor body 402 may be constructed by first removing carbon material from the core region near thecleaved end 408 of a SiC/C fiber by suitable techniques (as described above), to form thecavity 412 and then forming the insulatinglayer 409 over thecladding 406. - The
cavity 412 may then have applied therein anactive region 416. Theactive region 416 may include, as described in the previous embodiments, one or more catalytic agents adapted to promote an electrochemical reaction of the analyte into reaction products which produces electron flow in a workingelectrode 418 formed at an upper surface of thecore 404 within thecavity 412. Thecore 404 may form a portion of the workingelectrode 418 with or without an additional active layer (e.g., platinum). Moreover, thecladding 406 may form a portion of the working electrode as well. By the inclusion of the insulatinglayer 409 surrounding thecladding 406, areference electrode 420 may be coupled to the outer peripheral surface of thesensor 400 by placement directly in contact with the insulatinglayer 409, for example. Thereference electrode 420 may be made from Ag/AgCl layer or strip, a platinum film, and/or other suitable electrically conductive materials. -
FIG. 5 is a cross-sectional view of another embodiment of a test apparatus including another embodiment of alancet analyte sensor 500. In the depicted apparatus, thelancet analyte sensor 500 and thereference electrode 520 may be mounted in ahousing 513. Thehousing 513 may contain anelectrolytic fluid 514 such as a hydrogel, and thesensor 500 and thereference electrode 520 may be positioned within, and coupled to each other by, theelectrolytic fluid 514. As in the embodiment ofFIG. 2 , thelancet analyte sensor 500 may be extendable through aport 511 in thehousing 513 for the purposes of taking a bio-fluid sample, and then may be retractable back into theport 511 as illustrated byline 507. As thesensor 500 may be used for sample collection, it may have acleaved end 508 formed on thecladding 506 as described above, while thereference electrode 520 need not be used for sample collection, and therefore it need not have a cleaved end. In accordance with its sampling function, thesensor 500 may have acavity 512 for receiving a bio-fluid sample containing an analyte, anactive region 516 coupled to thecavity 512 including one or more catalytic agents or reagents, and a workingelectrode 518 coupled to theactive region 516. The workingelectrode 518 may comprise a portion of thecore 504 and or cladding 506 of thesensor 500, such as the end surface, which is exposed to theactive region 516. - In contrast, the
reference electrode 520 need not have acavity 512, and rather, the end of theconductive core 521 may be directly exposed to theelectrolytic fluid 514 in thehousing 513. The exposedcore 521 may act as areference electrode 520 adapted to detect charge carriers introduced into theelectrolytic fluid 514 from theactive region 516 ofsensor 500 because of the sensor's contact with thefluid 514. -
FIG. 6 depicts a cross-sectional view of another embodiment of alancet analyte sensor 600 according to the present invention. Thelancet sensor 600 may comprise acore 604 of a conductive material surrounded by acladding 606 of a semiconductor material wherein acavity 612 may be formed in the cladding and included proximate thecore 604. Alancet 610 may be provided by forming acleaved end 608 on thesensor 600, as in the previous embodiments. Thecore 604 and thecladding 606 may be manufactured from the materials as described previously. Areference electrode 620 may be coupled to thesensor 600 such as by being provided in thecavity 612 for example, similarly as described with reference toFIG. 3 . Other reference electrodes may be employed. In the depicted embodiment, thecore 604 may further include apocket 613 formed therein which may form part of thecavity 612. Anactive region 616 may be applied in thepocket 613. Because thepocket 613 may include a conductive material (e.g., graphite) along its sides, an effective contact area of theactive region 616 in contact with thecore 604 may be enlarged. -
FIG. 7A andFIG. 7B depict cross-sectional and frontal views, respectively, of another embodiment of alancet analyte sensor 700 according to the present invention. As in the previous embodiments, thelancet sensor 700 comprises a core 704 comprised of a conductive material which may be surrounded by acladding 706 comprised of a semiconductor material. Similarly, acavity 712 may be formed in thecladding 706 and may be provided proximate thecore 704. Alancet 710 may be provided by forming acleaved end 708 on thecladding 706 andcore 704. Thecore 704 and thecladding 706 may be manufactured from the materials described previously. In the depicted embodiment, thecavity 712 may be formed in thecladding 706 and the hollowed out area may be defined by the side walls of thecladding 706. Optionally, achannel 714 may be provided along the side of thecladding 706 to aid in the flow of a bio-fluid sample into thecavity 712. Anactive region 716 may be positioned in thecavity 712. Thecavity 712 may be any shape such as round, oval, or elongated, and may extend laterally from the surface of thecladding 706 to intersect with thecore 704 at a bottom of thecavity 712. Providing thecavity 712 along a side surface of thelancet analyte sensor 700 may minimize blockage of thecavity 712 by perforated bio-material (e.g., skin) as compared to when the cavity is located at an end of the sensor. Additional cavities (not shown) may be provided along the side such that additional analytes may be tested. -
FIG. 8 is a cross-sectional view of an additional embodiment of alancet analyte sensor 800 according to the present invention. As in the previous embodiments, thelancet sensor 800 may comprise asensor body 802 which may have a core 804 comprised of a conductive material surrounded by acladding 806 comprised of a semiconductor material. Similar to the previous embodiments, acavity 812 may be formed proximate thecore 804. In the depicted embodiment, thecavity 812 may be at least partially formed by inner walls of aseparate lancet member 817 which may be coupled to thesensor body 802 by a suitable coupler 821 (e.g., by a section of tubing). Thelancet member 817 may include an end having a portion that is separated from thebody 802 or cleaved at an angle thereby forming an enlarged portion in the cavity adjacent to thecore 804. The enlarged portion may allow additional area for applying theactive region 816. Thelancet member 817 may be formed of a hollow SiC fiber or other tubing material, such as stainless steel (e.g., an austenitic stainless steel). An exemplary length of thelancet member 817 may be about 2 microns to about 5 microns, although other lengths may be used. Alancet 810 may be provided by forming acleaved end 808 on thelancet member 817. In this embodiment, thecore 804 and thecladding 806 may be manufactured from the same materials described previously. As in the previous embodiments, theactive region 816 may be positioned in thecavity 812 in contact with thecore 804. Although not shown, a reference sensor may be provided on thesensor body 802, for example. - The embodiment of
FIG. 9 illustrates another embodiment oflancet analyte sensor 900 similar to the sensor ofFIG. 8 , except that it further includes areference sensor 920 positioned at the end of, and coupled to, thesensor body 902. Additionally, in some embodiments, thecoupler 921 include at least onevent hole 922. -
FIG. 10 illustrates an apparatus including an array ofsensors 1000. Thesensors 1000 may be arranged in any configuration, such as in a row or in any three dimensional arrangement (e.g., in a random or ordered pattern). By includingmultiple sensors 1000 in an array, the overall signal level may be enhanced, such as for continuous monitoring, for example. Any of the embodiments of sensors previously described may be incorporated into the array, such as those described with reference toFIG. 1A throughFIG. 9 . - In another aspect, the present invention provides a method of manufacturing an analyte sensor, including providing a fiber comprised of a semiconductor material; forming a cavity proximate to the fiber, applying an active region in the cavity, and forming lancet on the analyte sensor.
-
FIG. 11 illustrates a method of manufacturing an analyte sensor according to the present invention. Themethod 1100 includes astep 1102 wherein the fiber is provided including a semiconductor material. The fiber may be a SiC/C fiber as discussed above. The fiber is provided cut to the appropriate length. A cavity may then be formed proximate the fiber instep 1104. This may be by removal of a portion of the core, by the formation of a cavity in a side wall of the fiber, or by the attachment of a separate lancet member. An active region may be applied in contact with the fiber and in the cavity instep 1106 by methods described above. Instep 1108, a lancet may be formed on the analyte sensor. Of course, the steps may not be provided in the order shown. For example, the step of lancet formation instep 1108 may take place during the cutting operation. Likewise, the step of forming a cavity instep 1104 may be accomplished after the application of the active region, for example by adding a separate lancet member. Similarly, the step of forming the active region in the cavity may not occur until the attachment of a separate lancet member. - The foregoing description discloses only exemplary embodiments of the invention. Modifications of the above disclosed analyte sensors and apparatus incorporating them, which fall within the scope of the invention, will be readily apparent to those of ordinary skill in the art. Accordingly, while the present invention has been disclosed in connection with exemplary embodiments thereof, it should be understood that other embodiments may fall within the spirit and scope of the invention, as defined by the following claims.
Claims (20)
1. An analyte sensor, comprising:
a cylindrical sensor body;
an active region positioned within the cylindrical sensor body, the active region configured to determine an analyte concentration level; and
a fluid electrolyte in contact with at least a portion of the cylindrical sensor body.
2. The analyte sensor of claim 1 , wherein the sensor body comprises a core comprising a conductive material and a cladding surrounding the core comprising a semiconductor material.
3. The analyte sensor of claim 1 , further comprising a lancet positioned at an end of the cylindrical sensor body.
4. The analyte sensor of claim 3 , wherein the lancet is formed by a cleaved surface at the end of the cylindrical sensor body.
5. The analyte sensor of claim 3 , wherein the lancet comprises a separate lancet member coupled to the end of the cylindrical sensor body.
6. The analyte sensor of claim 1 , wherein the cylindrical sensor body has a cavity extending from an end of the cylindrical sensor body, the active region positioned at a bottom of the cavity.
7. The analyte sensor of claim 1 , further comprising a reference electrode, wherein the reference electrode is coupled to the fluid electrolyte.
8. The analyte sensor of claim 1 , wherein the cylindrical sensor body has a conduit and the active region is fluidly coupled to the fluid electrolyte via the conduit.
9. The analyte sensor of claim 1 , wherein the cylindrical sensor body is configured to extend and retract within a port in a housing.
10. An analyte sensor comprising:
a cylindrical sensor body;
an active region positioned within the cylindrical sensor body, the active region configured to determine an analyte concentration level; and
a reference electrode coupled to the cylindrical sensor body, wherein the reference electrode comprises a coil, foil, or film.
11. The analyte sensor of claim 10 , further comprising a lancet positioned at an end of the cylindrical sensor body.
12. The analyte sensor of claim 10 , further comprising a sealing material that surrounds the reference electrode and at least a portion of the cylindrical sensor body.
13. The analyte sensor of claim 10 , wherein the cylindrical sensor body comprises:
a core comprised of a conductive material;
a cladding comprised of a semiconductor material surrounding the core; and
a cavity formed proximate to the core; wherein:
the active region is positioned within the cavity.
14. An analyte sensor comprising:
a cylindrical sensor body having a cavity therein;
an active region positioned within the cavity, the active region configured to determine an analyte concentration level; and
a reference electrode positioned within the cavity.
15. The analyte sensor of claim 14 , wherein a distance separates the reference electrode from the active region in the cavity.
16. The analyte sensor of claim 14 , further comprising a lancet positioned at an end of the cylindrical sensor body.
17. The analyte sensor of claim 14 , wherein the cavity includes a pocket formed into a core of the cylindrical sensor body and the active region is applied in the pocket.
18. An analyte sensor comprising:
a cylindrical sensor body comprising:
a core comprised of a conductive material;
a cladding comprised of a semiconductor material; and
a cavity in the core extending from an end of the cylindrical sensor body;
an active region positioned at a bottom of the cavity, the active region configured to determine an analyte concentration level; and
a lancet positioned at the end of the cylindrical sensor body.
19. The analyte sensor of claim 18 , further comprising a first electrode in electrical contact with the active area and the core.
20. The analyte sensor of claim 19 , further comprising:
an insulating layer surrounding the cladding; and
a reference electrode at least partially surrounding the insulating layer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/681,684 US20150208959A1 (en) | 2008-09-19 | 2015-04-08 | Lancet analyte sensors and methods of manufacturing |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9871408P | 2008-09-19 | 2008-09-19 | |
PCT/US2009/057253 WO2010033660A1 (en) | 2008-09-19 | 2009-09-17 | Lancet analyte sensors and methods of manufacturing |
US201113119344A | 2011-03-16 | 2011-03-16 | |
US14/681,684 US20150208959A1 (en) | 2008-09-19 | 2015-04-08 | Lancet analyte sensors and methods of manufacturing |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/057253 Continuation WO2010033660A1 (en) | 2008-09-19 | 2009-09-17 | Lancet analyte sensors and methods of manufacturing |
US13/119,344 Continuation US9022953B2 (en) | 2008-09-19 | 2009-09-17 | Lancet analyte sensors and methods of manufacturing |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150208959A1 true US20150208959A1 (en) | 2015-07-30 |
Family
ID=42039856
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/119,344 Expired - Fee Related US9022953B2 (en) | 2008-09-19 | 2009-09-17 | Lancet analyte sensors and methods of manufacturing |
US14/679,798 Abandoned US20150208972A1 (en) | 2008-09-19 | 2015-04-06 | Lancet analyte sensors and methods of manufacturing |
US14/681,684 Abandoned US20150208959A1 (en) | 2008-09-19 | 2015-04-08 | Lancet analyte sensors and methods of manufacturing |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/119,344 Expired - Fee Related US9022953B2 (en) | 2008-09-19 | 2009-09-17 | Lancet analyte sensors and methods of manufacturing |
US14/679,798 Abandoned US20150208972A1 (en) | 2008-09-19 | 2015-04-06 | Lancet analyte sensors and methods of manufacturing |
Country Status (5)
Country | Link |
---|---|
US (3) | US9022953B2 (en) |
EP (1) | EP2341828A4 (en) |
CN (1) | CN102202575A (en) |
CA (1) | CA2735606A1 (en) |
WO (1) | WO2010033660A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009051901A2 (en) | 2007-08-30 | 2009-04-23 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
US8702932B2 (en) | 2007-08-30 | 2014-04-22 | Pepex Biomedical, Inc. | Electrochemical sensor and method for manufacturing |
EP2254458A1 (en) | 2008-02-04 | 2010-12-01 | Bayer HealthCare, LLC | Semiconductor based analyte sensors and methods |
CA2735666A1 (en) | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Analyte sensors, testing apparatus and manufacturing methods |
WO2010033748A1 (en) | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Electrical devices with enhanced electrochemical activity and manufacturing methods thereof |
CN102202575A (en) * | 2008-09-19 | 2011-09-28 | 拜尔健康护理有限责任公司 | Lancet analyte sensors and methods of manufacturing |
CN102196771A (en) | 2008-09-19 | 2011-09-21 | 拜尔健康护理有限责任公司 | Analyte sensors, systems, testing apparatus and manufacturing methods |
US11224367B2 (en) | 2012-12-03 | 2022-01-18 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
CN107003264B (en) | 2014-06-04 | 2020-02-21 | 普佩克斯生物医药有限公司 | Electrochemical sensor and method of manufacturing an electrochemical sensor using advanced printing techniques |
US10136848B2 (en) * | 2016-05-20 | 2018-11-27 | Winnoz Technology, Inc. | Device and system of blood collection, and method thereof |
WO2018075824A1 (en) * | 2016-10-20 | 2018-04-26 | EnLiSense, LLC | Multi-configurable sensing array and methods of using same |
CN114324529B (en) * | 2021-12-31 | 2024-02-23 | 嘉善君圆新材料科技有限公司 | Microelectrode for continuous electrochemical detection, biosensor and preparation method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4545382A (en) * | 1981-10-23 | 1985-10-08 | Genetics International, Inc. | Sensor for components of a liquid mixture |
US9022953B2 (en) * | 2008-09-19 | 2015-05-05 | Bayer Healthcare Llc | Lancet analyte sensors and methods of manufacturing |
US9173597B2 (en) * | 2008-09-19 | 2015-11-03 | Bayer Healthcare Llc | Analyte sensors, systems, testing apparatus and manufacturing methods |
US9439585B2 (en) * | 2008-02-04 | 2016-09-13 | Ascensia Diabetes Care Holdings Ag | Semiconductor based analyte sensors and methods |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4326927A (en) | 1980-07-25 | 1982-04-27 | Becton, Dickinson And Company | Method and device for the detection and measurement of electrochemically active compounds |
US4503856A (en) * | 1981-06-29 | 1985-03-12 | Sherwood Medical Company | Lancet injector |
JPS59106572A (en) | 1982-12-06 | 1984-06-20 | 信越化学工業株式会社 | Surface treatment of carbon fiber |
US5431160A (en) | 1989-07-19 | 1995-07-11 | University Of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
US5361314A (en) | 1992-09-04 | 1994-11-01 | The Regents Of The University Of Michigan | Micro optical fiber light source and sensor and method of fabrication thereof |
US5431800A (en) | 1993-11-05 | 1995-07-11 | The University Of Toledo | Layered electrodes with inorganic thin films and method for producing the same |
US5700695A (en) * | 1994-06-30 | 1997-12-23 | Zia Yassinzadeh | Sample collection and manipulation method |
JP3566377B2 (en) | 1995-03-01 | 2004-09-15 | 株式会社神戸製鋼所 | Diamond thin film biosensor |
US5611900A (en) * | 1995-07-20 | 1997-03-18 | Michigan State University | Microbiosensor used in-situ |
US5634913A (en) * | 1996-01-23 | 1997-06-03 | Stinger; Florence | Softening conduit for carrying fluids into and out of the human body |
US6218661B1 (en) | 1996-09-09 | 2001-04-17 | Schlumberger Technology Corporation | Methods and apparatus for mechanically enhancing the sensitivity of transversely loaded fiber optic sensors |
US5866353A (en) | 1996-12-09 | 1999-02-02 | Bayer Corporation | Electro chemical biosensor containing diazacyanine mediator for co-enzyme regeneration |
US20070142776A9 (en) * | 1997-02-05 | 2007-06-21 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
WO1999007277A1 (en) * | 1997-08-09 | 1999-02-18 | Roche Diagnostics Gmbh | Analytical device for in vivo analysis in the body of a patient |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6591125B1 (en) * | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
EP1085320A1 (en) | 1999-09-13 | 2001-03-21 | Interuniversitair Micro-Elektronica Centrum Vzw | A device for detecting an analyte in a sample based on organic materials |
ATE331214T1 (en) | 1999-10-07 | 2006-07-15 | Pepex Biomedical Llc | SENSOR, CONSISTING OF AN INSULATING SHEATH CONTAINING A MULTIPLE CONDUCTIVE FIBERS WHICH ARE AT LEAST PARTLY SURROUNDED BY A SENSITIVE MATERIAL AND CONTAIN VOIDS BETWEEN THE FIBERS |
US20020092612A1 (en) | 2000-03-28 | 2002-07-18 | Davies Oliver William Hardwicke | Rapid response glucose sensor |
DE10057832C1 (en) | 2000-11-21 | 2002-02-21 | Hartmann Paul Ag | Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample |
TWI313059B (en) | 2000-12-08 | 2009-08-01 | Sony Corporatio | |
US7310543B2 (en) * | 2001-03-26 | 2007-12-18 | Kumetrix, Inc. | Silicon microprobe with integrated biosensor |
US7011814B2 (en) | 2001-04-23 | 2006-03-14 | Sicel Technologies, Inc. | Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
US20020177763A1 (en) * | 2001-05-22 | 2002-11-28 | Burns David W. | Integrated lancets and methods |
US6824974B2 (en) | 2001-06-11 | 2004-11-30 | Genorx, Inc. | Electronic detection of biological molecules using thin layers |
US6793632B2 (en) * | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
US6814844B2 (en) | 2001-08-29 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor with code pattern |
US7074519B2 (en) | 2001-10-26 | 2006-07-11 | The Regents Of The University Of California | Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device |
FR2831790B1 (en) | 2001-11-06 | 2004-07-16 | Oreal | MEASUREMENT AND / OR ANALYSIS DEVICE OF AT LEAST ONE PARAMETER OF AN EXTERNAL PORTION OF THE HUMAN BODY |
US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
WO2004003535A1 (en) | 2002-06-27 | 2004-01-08 | Nanosys Inc. | Planar nanowire based sensor elements, devices, systems and methods for using and making same |
US7415299B2 (en) * | 2003-04-18 | 2008-08-19 | The Regents Of The University Of California | Monitoring method and/or apparatus |
NZ580449A (en) * | 2003-09-11 | 2011-06-30 | Theranos Inc | Ingestible medical device with biocompatible polymer coating, device with microarray to interact with disease marker |
US20080197024A1 (en) | 2003-12-05 | 2008-08-21 | Dexcom, Inc. | Analyte sensor |
US7138041B2 (en) | 2004-02-23 | 2006-11-21 | General Life Biotechnology Co., Ltd. | Electrochemical biosensor by screen printing and method of fabricating same |
JP4313703B2 (en) * | 2004-03-12 | 2009-08-12 | 彼方株式会社 | Information processing apparatus, system, method, and program |
US7299081B2 (en) * | 2004-06-15 | 2007-11-20 | Abbott Laboratories | Analyte test device |
US7601299B2 (en) | 2004-06-18 | 2009-10-13 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
AU2005309994B2 (en) | 2004-11-22 | 2011-09-29 | Trividia Health, Inc. | Biosensors comprising semiconducting electrodes or ruthenium containing mediators and method of using the same |
US7951632B1 (en) | 2005-01-26 | 2011-05-31 | University Of Central Florida | Optical device and method of making |
US20070096164A1 (en) | 2005-10-31 | 2007-05-03 | Peters Kevin F | Sensing system |
US7922971B2 (en) * | 2005-11-30 | 2011-04-12 | Abbott Diabetes Care Inc. | Integrated meter for analyzing biological samples |
EP2004796B1 (en) * | 2006-01-18 | 2015-04-08 | DexCom, Inc. | Membranes for an analyte sensor |
US8409093B2 (en) * | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
WO2010033748A1 (en) | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Electrical devices with enhanced electrochemical activity and manufacturing methods thereof |
CA2735666A1 (en) | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Analyte sensors, testing apparatus and manufacturing methods |
US8758583B2 (en) * | 2009-04-28 | 2014-06-24 | Abbott Diabetes Care Inc. | Smart sensor ports and methods of using same |
-
2009
- 2009-09-17 CN CN2009801419950A patent/CN102202575A/en active Pending
- 2009-09-17 CA CA2735606A patent/CA2735606A1/en not_active Abandoned
- 2009-09-17 EP EP09815166A patent/EP2341828A4/en not_active Withdrawn
- 2009-09-17 WO PCT/US2009/057253 patent/WO2010033660A1/en active Application Filing
- 2009-09-17 US US13/119,344 patent/US9022953B2/en not_active Expired - Fee Related
-
2015
- 2015-04-06 US US14/679,798 patent/US20150208972A1/en not_active Abandoned
- 2015-04-08 US US14/681,684 patent/US20150208959A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4545382A (en) * | 1981-10-23 | 1985-10-08 | Genetics International, Inc. | Sensor for components of a liquid mixture |
US9439585B2 (en) * | 2008-02-04 | 2016-09-13 | Ascensia Diabetes Care Holdings Ag | Semiconductor based analyte sensors and methods |
US9022953B2 (en) * | 2008-09-19 | 2015-05-05 | Bayer Healthcare Llc | Lancet analyte sensors and methods of manufacturing |
US9173597B2 (en) * | 2008-09-19 | 2015-11-03 | Bayer Healthcare Llc | Analyte sensors, systems, testing apparatus and manufacturing methods |
Non-Patent Citations (1)
Title |
---|
Cogan, et al. "Plasma‐enhanced chemical vapor deposited silicon carbide as an implantable dielectric coating." Journal of Biomedical Materials Research Part A 67.3 (2003): 856-867. * |
Also Published As
Publication number | Publication date |
---|---|
CA2735606A1 (en) | 2010-03-25 |
US20150208972A1 (en) | 2015-07-30 |
EP2341828A4 (en) | 2012-11-21 |
WO2010033660A1 (en) | 2010-03-25 |
US20110172559A1 (en) | 2011-07-14 |
EP2341828A1 (en) | 2011-07-13 |
US9022953B2 (en) | 2015-05-05 |
CN102202575A (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9022953B2 (en) | Lancet analyte sensors and methods of manufacturing | |
US10022080B2 (en) | Analyte sensors, systems, testing apparatus and manufacturing methods | |
US10307092B2 (en) | Semiconductor based analyte sensors and methods | |
KR100894975B1 (en) | Biological fluid constituent sampling and measurement devices | |
US6793632B2 (en) | Percutaneous biological fluid constituent sampling and measurement devices and methods | |
CA2428365C (en) | Physiological sample collection devices and methods of using the same | |
US10859525B2 (en) | Analyte sensors and methods of using same | |
US7060192B2 (en) | Methods of fabricating physiological sample collection devices | |
KR20020094899A (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
US20210361204A1 (en) | Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology | |
US20150313521A1 (en) | Sensor module and method of using a sensor module | |
US8551400B2 (en) | Analyte sensors, testing apparatus and manufacturing methods | |
US9309551B2 (en) | Electrical devices with enhanced electrochemical activity and manufacturing methods thereof | |
US10585059B2 (en) | Electrochemical test sensor | |
JP2004020465A (en) | Biosensor | |
CN209770384U (en) | Conductive probe for detecting glucose concentration information of in-vivo tissue fluid and electrochemical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ASCENSIA DIABETES CARE HOLDINGS AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER HEALTHCARE LLC;REEL/FRAME:038009/0227 Effective date: 20160104 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |